Vendeur
Revaluation Books, Exeter, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Vendeur AbeBooks depuis 6 janvier 2003
reprint edition. 272 pages. 9.50x6.50x0.50 inches. In Stock. N° de réf. du vendeur __111994077X
AN AUTHORITATIVE SURVEY OF CURRENT RESEARCH INTO CLINICALLY USEFUL CONVENTIONAL AND NONCONVENTIONAL ANTIBIOTIC THERAPEUTICS
Pharmaceutically-active antibiotics revolutionized the treatment of infectious diseases, leading to decreased mortality and increased life expectancy. However, recent years have seen an alarming rise in the number and frequency of antibiotic-resistant Superbugs. The Centers for Disease Control and Prevention (CDC) estimates that over two million antibiotic-resistant infections occur in the United States annually, resulting in approximately 23,000 deaths.
Despite the danger to public health, a minimal number of new antibiotic drugs are currently in development or in clinical trials by major pharmaceutical companies. To prevent reverting back to the pre-antibiotic era--when diseases caused by parasites or infections were virtually untreatable and frequently resulted in death--new and innovative approaches are needed to combat the increasing resistance of pathogenic bacteria to antibiotics.
Bacterial Resistance to Antibiotics - From Molecules to Man examines the current state and future direction of research into developing clinically-useful next-generation novel antibiotics. An internationally-recognized team of experts cover topics including glycopeptide antibiotic resistance, anti-tuberculosis agents, anti-virulence therapies, tetracyclines, the molecular and structural determinants of resistance, and more.
Bacterial Resistance to Antibiotics - From Molecules to Man is a valuable source of up-to-date information for medical practitioners, researchers, academics, and professionals in public health, pharmaceuticals, microbiology, and related fields.
À propos de l'auteur:
BOYAN B. BONEV is Associate Professor in Biophysics and Structural Biology, Faculty of Medicine & Health Sciences, University of Nottingham, UK. Dr. Bonev heads the Biomembrane NMR labs and is co-Director of the Dynamic Nuclear Magnetization Facility.
NICHOLAS M. BROWN is clinical lead for medical microbiology at Addenbrooke's Hospital, Cambridge. He is previous President and current Director of Public and Professional Engagement, British Society for Antimicrobial Chemotherapy (BSAC).
Titre : Bacterial Resistance to Antibiotics From ...
Éditeur : Wiley Blackwell
Date d'édition : 2019
Reliure : Paperback
Etat : Brand New